Sprache: Englisch
Verlag: Worthing Baptist Church, United Kingdom, 1978
Anbieter: RIVERLEE BOOKS, Waltham Cross, HERTS, Vereinigtes Königreich
EUR 12,79
Anzahl: 1 verfügbar
In den WarenkorbSoft cover. Zustand: Good. Good for year paperback (staple binding): The book is in good readable condition 15 pages.
Anbieter: Zubal-Books, Since 1961, Cleveland, OH, USA
Zustand: Good. 284 pp., Hardcover, ex library, else text clean and binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Sprache: Englisch
Verlag: Kluwer Academic Publishers, 1994
ISBN 10: 0792388720 ISBN 13: 9780792388722
Anbieter: Fireside Bookshop, Stroud, GLOS, Vereinigtes Königreich
Verbandsmitglied: PBFA
EUR 17,88
Anzahl: 1 verfügbar
In den WarenkorbCloth/Laminated Boards. Zustand: Very Good. Type: Book The timing of toxicological studies in relation to the clinical evaluation of new medicines is a key topic for strategic planners in the industry and those involved with harmonization. Resolving the anomalies between different regulatory authorities should eliminate redundant testing on animals and improve the efficiency of the developmental process by encouraging single international strategies. To aid industry in reaching a consensus, the Centre for Medicines Research has brought together representatives of the pharmaceutical industry from Europe, Japan and the USA to give a comprehensive account of current international industry positions on the subject. The contributions in this text review the situation and address the clinical and strategic requirements of the pre-clinical programme. Personal and consensus proposals on the toxicity studies required to initiate clinical investigations, the timing of reproductive toxicity tests and the duration of repeat-dose studies to support clinical development are provided. Small mark at base of spine.128pp.
Sprache: Englisch
Verlag: Kluwer Academic Publishers, 1998
ISBN 10: 0792387317 ISBN 13: 9780792387312
Anbieter: Fireside Bookshop, Stroud, GLOS, Vereinigtes Königreich
Verbandsmitglied: PBFA
EUR 23,84
Anzahl: 1 verfügbar
In den WarenkorbCloth/Laminated Boards. Zustand: Very Good. Type: Book At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory authorities are concentrating on improving their efficiency and effectiveness. Therefore, it is not surprising that questions are being asked as to how performance might be measured and compared between different authorities who are now often in receipt of dossiers that have been submitted to several agencies at the same time. Issues such as "what target should be set for the review of new medicines?" and "how can quality be assured?" are now considered to be of critical importance. The 12th CMR International Workshop, held in January 1997, provided the opportunity for regulatory authority and industry personnel from Europe, North America, Australia and Japan to openly discuss experiences and exchange views on how to improve the review process. The proceedings of this meeting provide a comprehensive overview of the current review process in different countries and the need for performance measures and targets. This volume summarizes the many suggestions that were debated at the workshop, and includes chapters on measuring performance, and on the integration of quality into the review process. 163pp.
Zustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: BargainBookStores, Grand Rapids, MI, USA
Paperback or Softback. Zustand: New. Improving the Regulatory Review Process: Assessing Performance and Setting Targets. Book.
Paperback or Softback. Zustand: New. The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines: Proceedings of a Workshop Held at the Medical Society of London, Uk, 7th and. Book.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 60,55
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 60,55
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 56,85
Anzahl: 10 verfügbar
In den WarenkorbPaperback. Zustand: New.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 56,93
Anzahl: 10 verfügbar
In den WarenkorbPaperback. Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 59,81
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 59,89
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Zustand: New. pp. xix + 163.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 66,58
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Kessinger Publishing, LLC, 2009
ISBN 10: 1120139171 ISBN 13: 9781120139177
Anbieter: moluna, Greven, Deutschland
EUR 34,18
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. KlappentextrnrnThis scarce antiquarian book is a facsimile reprint of the original. Due to its age, it may contain imperfections such as marks, notations, marginalia and flawed pages. Because we believe this work is culturally important, we have.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 77,06
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1997 edition. 163 pages. 9.45x6.30x0.43 inches. In Stock.
Sprache: Englisch
Verlag: Kessinger Publishing, LLC Sep 2009, 2009
ISBN 10: 1120139171 ISBN 13: 9781120139177
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - This scarce antiquarian book is a facsimile reprint of the original. Due to its age, it may contain imperfections such as marks, notations, marginalia and flawed pages. Because we believe this work is culturally important, we have made it available as part of our commitment for protecting, preserving, and promoting the world's literature in affordable, high quality, modern editions that are true to the original work.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 93,52
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 93,52
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: GreatBookPrices, Columbia, MD, USA
EUR 119,64
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory Authorities are concentrating on improving their efficiency and effectiveness. Therefore, it is not surprising that questions are being asked as to how performance might be measured and compared between different authorities who are now often in receipt of dossiers that have been submitted to several agencies at the same time. Issues such as 'what target should be set for the review of new medicines ' and `how can quality be assured ' are now considered to be of critical importance. The twelfth CMR International Workshop, held in January 1997, provided the opportunity for Regulatory Authority and industry personnel from Europe, North America, Australia and Japan to openly discuss experiences and exchange views on how to improve the review process. The proceedings of this meeting provide a comprehensive overview of the current review process in different countries and the need for performance measures and targets. This volume summarises the many suggestions that were debated at the Workshop, and includes chapters on measuring performance, and on the integration of quality into the review process.
Taschenbuch. Zustand: Neu. The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines | Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993 | S. R. Walker (u. a.) | Taschenbuch | xviii | Englisch | 2013 | Springer | EAN 9789401046213 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Improving the Regulatory Review Process: Assessing Performance and Setting Targets | N. McAuslane (u. a.) | Taschenbuch | Centre for Medicines Research Workshop | xix | Englisch | 2012 | Springer | EAN 9789401060424 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Springer, Springer Netherlands, 2012
ISBN 10: 9401046212 ISBN 13: 9789401046213
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include the United States. Japan. Germany. France. Italy. UK and Canada. which together represent approximately 85% of the pharmaceutical market in the developed world. The mutual acceptance of foreign clinical data would reduce the time and resources required to develop a new medicine for the international market by eliminating the requirement for the routine repetition of clinical studies in local populations. In Japan this has been largely based on the belief that genetic differences in respon siveness may result in a different benefit/risk assessment for a new mediCine. while requests in Europe and the United States for local data relate mainly to methodological and cultural considerations. The importance of this issue has been recognised internationally as it was one of the topics discussed at the International Conference on Harmonisation in Orlando (October 1993) and it is currently on the programme for ICH3 which will be convened in Yokohama in Japan in November 1995.